
Medicine and Health
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
A. Medina, N. Puig, et al.
This groundbreaking study conducted by Alejandro Medina and colleagues reveals the critical role of minimal residual disease (MRD) detection in predicting outcomes for multiple myeloma patients. Using advanced NGS and NGF technologies, the research uncovers significant correlations and highlights the stark difference in survival rates for MRD-negative patients three months post-transplantation. Discover the importance of MRD monitoring in transforming patient care.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.